Table 2.
Analysis of numerous factors that might be related to overall survival
| Number of patients | p-value | |
|---|---|---|
| Age | ||
| < 65 years | 43 (33%) | <0.05 |
| > 65 years | 86 (67%) | <0.05 |
| Stage of disease (Salmon-Durie) | ||
| I | 8 (6%) | Ns |
| II | 20 (16%) | Ns |
| III | 101(78%) | <0.05 |
| Radiotherapy | ||
| Yes | 85 (66%) | Ns |
| No | 44 (34%) | Ns |
| Time to initial diagnosis | ||
| < 1 year | 23 (8%) | Ns |
| 1–2 years | 48 (37%) | Ns |
| > 3 years | 71 (55%) | <0.05 |
| CRP level | ||
| < 5 mg/l | 91 (70%) | Ns |
| > 5 mg/l | 38 (30%) | Ns |
| Peripheral blood stem cell transplantation | ||
| Yes | 71 (55%) | Ns |
| No | 58 (45%) | Ns |
| Lactate dehydrogenase | ||
| < 240 U/l | 93 (72%) | Ns |
| > 240 U/l | 36 (28%) | Ns |
| Beta-2 microglobulin | ||
| < 3.5 mg/l | 8 (6%) | Ns |
| 3.5–5.5 mg/l | 31 (24%) | Ns |
| > 5.5 mg/l | 90 (70%) | Ns |